Advanced Search

Technical Analysis for ANVS - Annovis Bio, Inc.

Grade Last Price % Change Price Change
grade D 5.76 -4.00% -0.24
ANVS closed down 4.0 percent on Friday, February 21, 2020, on 14 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
0 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical ANVS trend table...
Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Hot IPO Pullback Bullish Swing Setup -4.00%
Calm After Storm Range Contraction -4.00%
Outside Day Range Expansion -4.00%
Hot IPO Pullback Bullish Swing Setup -1.87%
Calm After Storm Range Contraction -1.87%
Older EOD signals for ANVS ...
View Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
ANVS Chart by TradingView
Basic chart:

Profile

Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
Organ Systems Alzheimer's Disease Nervous System Psychiatric Diagnosis Alzheimer's Cognitive Disorders Neurodegeneration Neurodegenerative Disorders Learning Disabilities Mild Cognitive Impairment Neuroprotection

Is ANVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Feb 23 The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
Feb 22 Stocks To Watch: JPMorgan, Virgin Galactic, Peloton Put To The Test
Feb 20 Annovis Bio up 6% premarket on new U.S. patent covering lead candidate
Feb 20 Annovis Issued Patent for Method of Treating Parkinson’s Disease and Other Lewy Body Diseases
Feb 18 Bellerophon Therapeutics leads healthcare gainers; ImmunoGen among losers
Feb 13 Annovis Bio Announces Update on Phase II Clinical Trial for Alzheimer’s Disease
Jan 31 54 Stocks Moving In Friday's Mid-Day Session
Jan 31 Annovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 30 Mid-Morning Market Update: Markets Edge Lower; Coca-Cola Posts Upbeat Q4 Revenue
Jan 29 Annovis Bio prices initial public offering
See more ANVS news...

Indicators

Indicator Value
52 Week High 10.61
52 Week Low 5.0
Average Volume 242,994
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 5.84
Average True Range 1.14
ADX 0.0
+DI 12.12
-DI 16.40
Chandelier Exit (Long, 3 ATRs ) 7.19
Chandelier Exit (Short, 3 ATRs ) 8.42
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line -0.12
MACD Signal Line -0.04
MACD Histogram -0.0764
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.15
Resistance 3 (R3) 6.19 6.10 6.09
Resistance 2 (R2) 6.10 6.00 6.08 6.06
Resistance 1 (R1) 5.93 5.94 5.89 5.89 6.04
Pivot Point 5.84 5.84 5.82 5.82 5.84
Support 1 (S1) 5.67 5.74 5.63 5.63 5.48
Support 2 (S2) 5.58 5.68 5.56 5.46
Support 3 (S3) 5.41 5.58 5.44
Support 4 (S4) 5.37